Cargando…
High Expression of F-Box Protein 43 Is Associated With Poor Prognosis and Adjuvant Chemotherapy Resistance in Colorectal Cancer
BACKGROUND: The F-box protein 43 (FBXO43), also referred to as endogenous meiotic inhibitor 2 (EMI2), has been linked to the advancement of various types of cancer, such as hepatocellular carcinoma, breast cancer, cholangiocarcinoma, and gastric cancer. Nevertheless, the precise function of FBXO43 i...
Autores principales: | Liu, Junyu, Yang, Xi, Li, Miao, Liu, Ying Ying, Wang, Yulan, Li, Shichao, Zheng, Fengping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409561/ https://www.ncbi.nlm.nih.gov/pubmed/37560338 http://dx.doi.org/10.14740/wjon1642 |
Ejemplares similares
-
Association between F‐box‐only protein 43 overexpression and hepatocellular carcinoma pathogenesis and prognosis
por: Wu, Shaohan, et al.
Publicado: (2023) -
High expression of HSP90 is associated with poor prognosis in patients with colorectal cancer
por: Zhang, Shuming, et al.
Publicado: (2019) -
The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer
por: Chu-Yuan, Hong, et al.
Publicado: (2013) -
Effect of adjuvant chemotherapy after pulmonary metastasectomy on the prognosis of colorectal cancer
por: Shiomi, Kazu, et al.
Publicado: (2017) -
Desmoplastic Reaction Associates with Prognosis and Adjuvant Chemotherapy Response in Colorectal Cancer: A Multicenter Retrospective Study
por: Hu, Qingru, et al.
Publicado: (2023)